University of Rhode Island - College of Pharmacy Revenue and Competitors
Estimated Revenue & Valuation
- University of Rhode Island - College of Pharmacy's estimated annual revenue is currently $16.9M per year.
- University of Rhode Island - College of Pharmacy's estimated revenue per employee is $180,000
Employee Data
- University of Rhode Island - College of Pharmacy has 94 Employees.
- University of Rhode Island - College of Pharmacy grew their employee count by 25% last year.
University of Rhode Island - College of Pharmacy's People
Name | Title | Email/Phone |
---|
University of Rhode Island - College of Pharmacy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.8M | 33 | 10% | N/A | N/A |
#2 | $22.9M | 127 | 9% | N/A | N/A |
#3 | $154.8M | 688 | -1% | N/A | N/A |
#4 | $25M | 139 | 15% | N/A | N/A |
#5 | $4.9M | 34 | 36% | N/A | N/A |
#6 | $54.1M | 273 | 6% | N/A | N/A |
#7 | $5.2M | 36 | 44% | N/A | N/A |
#8 | $75.6M | 336 | 6% | N/A | N/A |
#9 | $6.6M | 46 | 2% | N/A | N/A |
#10 | $101M | 449 | N/A | N/A | N/A |
What Is University of Rhode Island - College of Pharmacy?
The University of Rhode Island College of Pharmacy was founded in 1902 and is one of the oldest schools of pharmacy in the United States. We are based in Kingston, RI, approximately 30 minutes south of Providence. The College offers a 6 year Doctor of Pharmacy degree and BS, MS and PhD degrees in Pharmaceutical Sciences and Interdisciplinary Neuroscience. We are consistently ranked in the top 10 percent of United States schools of pharmacy in federal research funding, postdoctoral residency placement, pharmacy board passage rate and graduating student employment and program satisfaction.
keywords:N/AN/A
Total Funding
94
Number of Employees
$16.9M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $31.2M | 95 | 30% | N/A |
#2 | $14.1M | 97 | -23% | N/A |
#3 | $15.8M | 97 | 33% | N/A |
#4 | $21.6M | 98 | -1% | N/A |
#5 | $15M | 99 | 22% | N/A |